# 18.14.8 Pulmonary amyloidosis 4261 S.J. Bourke

# 18.14.8 Pulmonary amyloidosis 4261 S.J. Bourke

Contents
xxvi
18.11	 Diffuse parenchymal lung diseases  4166
	
18.11.1	 Diffuse parenchymal lung disease: An 
introduction  4166
F. Teo and A.U. Wells
	
18.11.2	 Idiopathic pulmonary fibrosis  4177
P.L. Molyneaux, A.G. Nicholson, N. Hirani, and 
A.U. Wells
	
18.11.3	 Bronchiolitis obliterans and cryptogenic  
organizing pneumonia  4185
Vasilis Kouranos and A.U. Wells
	
18.11.4	 The lung in autoimmune rheumatic 
disorders  4191
M.A. Kokosi and A.U. Wells
	
18.11.5	 The lung in vasculitis  4200
G.A. Margaritopoulos and A.U. Wells
18.12	 Sarcoidosis  4208
Robert P. Baughman and Elyse E. Lower
18.13	 Pneumoconioses  4219
P.T. Reid
18.14	 Miscellaneous conditions  4235
	
18.14.1	 Diffuse alveolar haemorrhage  4235
S.J. Bourke and G.P. Spickett
	
18.14.2	 Eosinophilic pneumonia  4238
S.J. Bourke and G.P. Spickett
	
18.14.3	 Lymphocytic infiltrations of the  
lung  4241
S.J. Bourke
	
18.14.4	 Hypersensitivity pneumonitis  4244
S.J. Bourke and G.P. Spickett
	
18.14.5	 Pulmonary Langerhans’ cell  
histiocytosis  4256
S.J. Bourke
	
18.14.6	 Lymphangioleiomyomatosis  4257
S.J. Bourke
	
18.14.7	 Pulmonary alveolar proteinosis  4259
S.J. Bourke
	
18.14.8	 Pulmonary amyloidosis  4261
S.J. Bourke
	
18.14.9	 Lipoid (lipid) pneumonia  4263
S.J. Bourke
	
18.14.10	 Pulmonary alveolar microlithiasis  4265
S.J. Bourke
	
18.14.11	 Toxic gases and aerosols  4267
Chris Stenton
	
18.14.12	 Radiation pneumonitis  4271
S.J. Bourke
	
18.14.13	 Drug-​induced lung disease  4272
S.J. Bourke
18.15	 Chronic respiratory failure  4282
Michael I. Polkey and P.M.A. Calverley
18.16	 Lung transplantation  4292
P. Hopkins and A.J. Fisher
18.17	 Pleural diseases  4305
D. de Fonseka, Y.C. Gary Lee, and N.A. Maskell
18.18	 Disorders of the thoracic cage and 
diaphragm  4328
John M. Shneerson and Michael I. Polkey
18.19	 Malignant diseases  4338
	
18.19.1	 Lung cancer  4338
S.G. Spiro and N. Navani
	
18.19.2	 Pulmonary metastases  4360
S.G. Spiro
	
18.19.3	 Pleural tumours  4361
Y.C. Gary Lee
	
18.19.4	 Mediastinal tumours and cysts  4368
Y.C. Gary Lee and Helen E. Davies
SECTION 19
Rheumatological disorders	
Section editor: Richard A. Watts
19.1	 Joints and connective tissue—​structure and 
function  4379
Thomas Pap, Adelheid Korb-​Pap, Christine Hartmann, and 
Jessica Bertrand
19.2	 Clinical presentation and diagnosis of 
rheumatological disorders  4386
Christopher Deighton and Fiona Pearce
19.3	 Clinical investigation  4395
Michael Doherty and Peter C. Lanyon
19.4	 Back pain and regional disorders  4406
Carlo Ammendolia and Danielle Southerst
19.5	 Rheumatoid arthritis  4415
Kenneth F. Baker and John D. Isaacs
19.6	 Spondyloarthritis and related conditions  4441
Jürgen Braun and Joachim Sieper
19.7	 Infection and arthritis  4457
Graham Raftery and Muddassir Shaikh
19.8	 Reactive arthritis  4464
Carmel B. Stober and Hill Gaston
19.9	 Osteoarthritis  4470
Andrew J. Barr and Philip G. Conaghan


Contents
xxvii
19.10	 Crystal-​related arthropathies  4482
Edward Roddy and Michael Doherty
19.11	 Autoimmune rheumatic disorders and 
vasculitides  4495
	
19.11.1	 Introduction  4495
David A. Isenberg and Ian Giles
	
19.11.2	 Systemic lupus erythematosus and related 
disorders  4499
Anisur Rahman and David A. Isenberg
	
19.11.3	 Systemic sclerosis (scleroderma)  4513
Christopher P. Denton and Carol M. Black
	
19.11.4	 Sjögren’s syndrome  4532
Wan-​Fai Ng
	
19.11.5	 Inflammatory myopathies  4537
Ingrid E. Lundberg, Hector Chinoy, and  
Robert Cooper
	
19.11.6	 Large vessel vasculitis  4546
Raashid Luqmani and Cristina Ponte
	
19.11.7	 ANCA-​associated vasculitis  4556
David Jayne
	
19.11.8	 Polyarteritis nodosa  4569
Loïc Guillevin
	
19.11.9	 Small vessel vasculitis  4573
Richard A. Watts
	
19.11.10	 Behçet’s syndrome  4579
Sebahattin Yurdakul, Izzet Fresko, and  
Hasan Yazici
	
19.11.11	 Polymyalgia rheumatica  4584
Bhaskar Dasgupta and Eric L. Matteson
	
19.11.12	 Kawasaki disease  4590
Brian W. McCrindle
19.12	 Miscellaneous conditions presenting to the 
rheumatologist  4598
Stuart Carter, Lisa Dunkley, and Ade Adebajo
SECTION 20
Disorders of the skeleton	
Section editor: Cyrus Cooper
20.1	 Skeletal disorders—​general approach and clinical 
conditions  4615
B. Paul Wordsworth and M.K. Javaid
20.2	 Inherited defects of connective tissue:  
Ehlers–​Danlos syndrome, Marfan’s syndrome, 
and pseudoxanthoma elasticum  4670
N.P. Burrows
20.3	 Osteomyelitis  4688
Martin A. McNally and Anthony R. Berendt
20.4	 Osteoporosis  4696
Nicholas C. Harvey, Juliet Compston, and Cyrus Cooper
20.5	 Osteonecrosis, osteochondrosis, and 
osteochondritis dissecans  4703
Gavin Clunie
20.6	 Bone cancer  4709
Helen Hatcher
SECTION 21
Disorders of the kidney and  
urinary tract	
Section editor: John D. Firth
21.1	 Structure and function of the kidney  4717
Steve Harper and Robert Unwin
21.2	 Electrolyte disorders  4729
	
21.2.1	 Disorders of water and sodium homeostasis  4729
Michael L. Moritz and Juan Carlos Ayus
	
21.2.2	 Disorders of potassium homeostasis  4748
John D. Firth
21.3	 Clinical presentation of renal disease  4764
Richard E. Fielding and Ken Farrington
21.4	 Clinical investigation of renal disease  4781
Andrew Davenport
21.5	 Acute kidney injury  4807
John D. Firth
21.6	 Chronic kidney disease  4830
Alastair Hutchison
21.7	 Renal replacement therapy  4861
	
21.7.1	 Haemodialysis  4861
Robert Mactier
	
21.7.2	 Peritoneal dialysis  4874
Simon Davies
	
21.7.3	 Renal transplantation  4879
Nicholas Torpey and John D. Firth
21.8	 Glomerular diseases  4909
	
21.8.1	 Immunoglobulin A nephropathy and IgA  
vasculitis (HSP)  4909
Jonathan Barratt and John Feehally
	
21.8.2	 Thin membrane nephropathy  4918
Peter Topham and John Feehally


Contents
xxviii
	
21.8.3	
Minimal-​change nephropathy and focal 
segmental glomerulosclerosis  4919
Moin Saleem and Lisa Willcocks
	
21.8.4	
Membranous nephropathy  4928
An S. De Vriese and Fernando C. Fervenza
	
21.8.5	
Proliferative glomerulonephritis  4933
Alan D. Salama and Mark A. Little
	
21.8.6	
Membranoproliferative glomerulonephritis  4937
Tabitha Turner-​Stokes and Mark A. Little
	
21.8.7	
Antiglomerular basement membrane  
disease  4943
Mårten Segelmark and Thomas Hellmark
21.9	
Tubulointerstitial diseases  4951
	
21.9.1	
Acute interstitial nephritis  4951
Simon D. Roger
	
21.9.2	
Chronic tubulointerstitial nephritis  4956
Marc E. De Broe, Channa Yamasumana,  
Patrick C. D’Haese, Monique M. Elseviers, and  
Benjamin Vervaet
21.10	 The kidney in systemic disease  4975
	
21.10.1	 Diabetes mellitus and the kidney  4975
Rudolf Bilous
	
21.10.2	 The kidney in systemic vasculitis  4988
David Jayne
	
21.10.3	 The kidney in rheumatological  
disorders  5001
Liz Lightstone and Hannah Beckwith
	
21.10.4	 The kidney in sarcoidosis  5012
Ingeborg Hilderson and Jan Donck
	
21.10.5	 Renal involvement in plasma cell dyscrasias, 
immunoglobulin-​based amyloidoses, and 
fibrillary glomerulopathies, lymphomas, and 
leukaemias  5016
Pierre Ronco, Frank Bridoux, and Arnaud Jaccard
	
21.10.6	 Haemolytic uraemic syndrome  5027
Edwin K.S. Wong and David Kavanagh
	
21.10.7	 Sickle cell disease and the kidney  5032
Claire C. Sharpe
	
21.10.8	 Infection-​associated nephropathies  5034
A. Neil Turner
	
21.10.9	 Malignancy-​associated renal disease  5041
A. Neil Turner
	
21.10.10	 Atherosclerotic renovascular disease  5044
Philip A. Kalra and Diana Vassallo
21.11	 Renal diseases in the tropics  5049
Vivekanand Jha
21.12	 Renal involvement in genetic disease  5065
D. Joly and J.P. Grünfeld
21.13	 Urinary tract infection  5074
Charles Tomson and Neil Sheerin
21.14	 Disorders of renal calcium handling, urinary 
stones, and nephrocalcinosis  5093
Christopher Pugh, Elaine M. Worcester, Andrew P. Evan, and 
Fredric L. Coe
21.15	 The renal tubular acidoses  5104
John A. Sayer and Fiona E. Karet
21.16	 Disorders of tubular electrolyte handling  5112
Nine V.A.M. Knoers and Elena N. Levtchenko
21.17	 Urinary tract obstruction  5124
Muhammad M. Yaqoob and Kieran McCafferty
21.18	 Malignant diseases of the urinary tract  5136
Tim Eisen, Freddie C. Hamdy, and Robert A. Huddart
21.19	 Drugs and the kidney  5150
Aine Burns and Caroline Ashley
Index
Volume 4
List of abbreviations  xxxv
List of contributors  xlv
SECTION 22
Haematological disorders	
Section editors: Chris Hatton and Deborah Hay
22.1	 Introduction to haematology  5169
Chris Hatton
22.2	 Haematopoiesis  5172
	
22.2.1	 Cellular and molecular basis of haematopoiesis  5172
Paresh Vyas and N. Asger Jakobsen
	
22.2.2	 Diagnostic techniques in the assessment of 
haematological malignancies  5181
Wendy N. Erber


Contents
xxix
22.3	 Myeloid disease  5189
	
22.3.1	 Granulocytes in health and disease  5189
Joseph Sinning and Nancy Berliner
	
22.3.2	 Myelodysplastic syndromes  5197
Charlotte K. Brierley and David P. Steensma
	
22.3.3	 Acute myeloid leukaemia  5205
Nigel Russell and Alan Burnett
	
22.3.4	 Chronic myeloid leukaemia  5213
Mhairi Copland and Tessa L. Holyoake†
	
22.3.5	 The polycythaemias  5227
Daniel Aruch and Ronald Hoffman
	
22.3.6	 Thrombocytosis and essential 
thrombocythaemia  5239
Daniel Aruch and Ronald Hoffman
	
22.3.7	 Primary myelofibrosis  5247
Evan M. Braunstein and Jerry L. Spivak
	
22.3.8	 Eosinophilia  5254
Peter F. Weller
	
22.3.9	 Histiocytosis  5259
Chris Hatton
22.4	 Lymphoid disease  5263
	
22.4.1	 Introduction to lymphopoiesis  5263
Caron A. Jacobson and Nancy Berliner
	
22.4.2	 Acute lymphoblastic leukaemia  5269
H. Josef Vormoor, Tobias F. Menne, and  
Anthony V. Moorman
	
22.4.3	 Hodgkin lymphoma  5280
Vijaya Raj Bhatt and James O. Armitage
	
22.4.4	 Non-​Hodgkin lymphoma  5288
Vijaya Raj Bhatt and James O. Armitage
	
22.4.5	 Chronic lymphocytic leukaemia  5302
Clive S. Zent and Aaron Polliack
	
22.4.6	 Plasma cell myeloma and related monoclonal 
gammopathies  5310
S. Vincent Rajkumar and Robert A. Kyle
22.5	 Bone marrow failure  5325
	
22.5.1	 Inherited bone marrow failure syndromes  5325
Irene Roberts and Inderjeet S. Dokal
	
22.5.2	 Acquired aplastic anaemia and pure red cell 
aplasia  5336
Judith C.W. Marsh, Shreyans Gandhi,  
and Ghulam J. Mufti
	
22.5.3	 Paroxysmal nocturnal haemoglobinuria  5348
Lucio Luzzatto
22.6	
Erythroid disorders  5354
	
22.6.1	
Erythropoiesis  5354
Vijay G. Sankaran
	
22.6.2	
Anaemia: pathophysiology, classification, and 
clinical features  5359
David J. Weatherall† and Chris Hatton
	
22.6.3	
Anaemia as a challenge to world health  5366
David J. Roberts and David J. Weatherall†
	
22.6.4	
Iron metabolism and its disorders  5371
Timothy M. Cox and John B. Porter
	
22.6.5	
Anaemia of inflammation  5402
Sant-​Rayn Pasricha and Hal Drakesmith
	
22.6.6	
Megaloblastic anaemia and miscellaneous 
deficiency anaemias  5407
A.V. Hoffbrand
	
22.6.7	
Disorders of the synthesis or function of 
haemoglobin  5426
Deborah Hay and David J. Weatherall†
	
22.6.8	
Anaemias resulting from defective maturation  
of red cells  5450
Stephen J. Fuller and James S. Wiley
	
22.6.9	
Disorders of the red cell membrane  5456
Patrick G. Gallagher
	
22.6.10	 Erythrocyte enzymopathies  5463
Alberto Zanella and Paola Bianchi
	
22.6.11	
 Glucose-​6-​phosphate dehydrogenase 
deficiency  5472
Lucio Luzzatto
	
22.6.12	 Acquired haemolytic anaemia  5479
Amy Powers and Leslie Silberstein
22.7	
Haemostasis  5490
	
22.7.1	
The biology of haemostasis and  
thrombosis  5490
Gilbert C. White, II, Harold R. Roberts,  
and Nigel S. Key
	
22.7.2	
Evaluation of the patient with a bleeding 
tendency  5509
Trevor Baglin
	
22.7.3	
Thrombocytopenia and disorders of platelet 
function  5520
Nicola Curry and Susie Shapiro
	
22.7.4	
Genetic disorders of coagulation  5532
Eleanor S. Pollak and Katherine A. High
	
22.7.5	
Acquired coagulation disorders  5546
T.E. Warkentin
† It is with great regret that we report that Tessa L. Holyoake died on 30 August, 
2017.
† It is with great regret that we report that David J. Weatherall died on 8 December, 
2018.


Contents
xxx
22.8	
Transfusion and transplantation  5563
	
22.8.1	 Blood transfusion  5563
D.S. Giovanniello and E.L. Snyder
	
22.8.2	 Haemopoietic stem cell transplantation  5579
E.C. Gordon-​Smith and Emma C. Morris
SECTION 23
Disorders of the skin	
Section editor: Roderick J. Hay
23.1	
Structure and function of skin  5591
John A. McGrath
23.2	
Clinical approach to the diagnosis of skin 
disease  5596
Vanessa Venning
23.3	
Inherited skin disease  5602
Thiviyani Maruthappu and David P. Kelsell
23.4	
Autoimmune bullous diseases  5612
Kathy Taghipour and Fenella Wojnarowska
23.5	
Papulosquamous disease  5621
Christopher E.M. Griffiths
23.6	
Dermatitis/​eczema  5630
Peter S. Friedmann, Michael J. Arden-​Jones, and Roderick J. Hay
23.7	
Cutaneous vasculitis, connective tissue 
diseases, and urticaria  5639
Volha Shpadaruk and Karen E. Harman
23.8	
Disorders of pigmentation  5677
Eugene Healy
23.9	
Photosensitivity  5688
Hiva Fassihi and Jane McGregor
23.10	 Infections of the skin  5695
Roderick J. Hay
23.11	 Sebaceous and sweat gland disorders  5699
Alison M. Layton
23.12	 Blood and lymphatic vessel disorders  5709
Peter S. Mortimer and Roderick J. Hay
23.13	 Hair and nail disorders  5724
David de Berker
23.14	 Tumours of the skin  5732
Edel O’Toole
23.15	 Skin and systemic diseases  5743
Clive B. Archer and Charles M.G. Archer
23.16	 Cutaneous reactions to drugs  5752
Sarah Walsh, Daniel Creamer, and Haur Yueh Lee
23.17	 Management of skin disease  5761
Rod Sinclair
SECTION 24
Neurological disorders	
Section editor: Christopher Kennard
24.1	 Introduction and approach to the patient with 
neurological disease  5775
Alastair Compston and Christopher Kennard
24.2	 Mind and brain: Building bridges  
between neurology, psychiatry, and 
psychology  5778
Adam Zeman
24.3	 Clinical investigation of neurological disease  5781
	
24.3.1	 Lumbar puncture  5781
R. Rhys Davies and Andrew J. Larner
	
24.3.2	 Electrophysiology of the central and peripheral 
nervous systems  5785
Christian Krarup
	
24.3.3	 Imaging in neurological diseases  5802
Andrew J. Molyneux, Shelley Renowden, and  
Marcus Bradley
	
24.3.4	 Investigation of central motor pathways:  
Magnetic brain stimulation  5817
K.R. Mills
24.4	 Higher cerebral function  5821
	
24.4.1	 Disturbances of higher cerebral function  5821
Peter J. Nestor
	
24.4.2	 Alzheimer’s disease and other dementias  5830
Jonathan M. Schott
24.5	 Epilepsy and disorders of consciousness  5860
	
24.5.1	 Epilepsy in later childhood and adulthood  5860
Arjune Sen and M.R. Johnson
	
24.5.2	 Narcolepsy  5882
Matthew C. Walker
	
24.5.3	 Sleep disorders  5886
Paul J. Reading
	
24.5.4	 Syncope  5896
Andrew J. Larner
	
24.5.5	 The unconscious patient  5901
David Bates


Contents
xxxi
	
24.5.6	 Brainstem death and prolonged disorders of 
consciousness  5908
Ari Ercole, Peter J. Hutchinson, and John D. Pickard
24.6	
Disorders of the special senses  5913
	
24.6.1	 Visual pathways  5913
Sara Ajina and Christopher Kennard
	
24.6.2	 Eye movements and balance  5922
Michael Strupp and Thomas Brandt
	
24.6.3	 Hearing loss  5931
Linda Luxon
24.7	
Disorders of movement  5937
	
24.7.1	 Subcortical structures: The cerebellum, basal 
ganglia, and thalamus  5937
Mark J. Edwards and Penelope Talelli
	
24.7.2	 Parkinsonism and other extrapyramidal 
diseases  5946
Elisaveta Sokolov, Vinod K. Metta, and K. Ray 
Chaudhuri
	
24.7.3	 Movement disorders other than Parkinson’s 
disease  5956
Bettina Balint and Kailash Bhatia
	
24.7.4	 Ataxic disorders  5976
Nicholas Wood
24.8	
Headache  5987
Peter J. Goadsby
24.9	
Brainstem syndromes  6006
David Bates
24.10	 Specific conditions affecting the central 
nervous system  6010
	
24.10.1	 Stroke: Cerebrovascular disease  6010
J. van Gijn (revised by Peter M. Rothwell)
	
24.10.2	 Demyelinating disorders of the central nervous 
system  6026
Alasdair Coles and Siddharthan Chandran
	
24.10.3	 Traumatic brain injury  6042
Tim Lawrence and Laurence Watkins
	
24.10.4	 Intracranial tumours  6048
Jeremy Rees
	
24.10.5	 Idiopathic intracranial hypertension  6054
Alexandra Sinclair
24.11	 Infections of the central nervous system  6060
	
24.11.1	 Bacterial infections  6060
Diederik van de Beek and Guy E. Thwaites
	
24.11.2	 Viral infections  6082
Fiona McGill, Jeremy Farrar, Bridget Wills, Menno  
De Jong, David A. Warrell, and Tom Solomon
	
24.11.3	 Intracranial abscesses  6097
Tim Lawrence and Richard S.C. Kerr
	
24.11.4	 Neurosyphilis and neuro-​AIDS  6100
Hadi Manji
	
24.11.5	 Human prion diseases  6109
Simon Mead and R.G. Will
24.12	 Disorders of cranial nerves  6120
Robert D.M. Hadden
24.13	 Disorders of the spinal cord  6127
	
24.13.1	 Diseases of the spinal cord  6127
Anu Jacob and Andrew J. Larner
	
24.13.2	 Spinal cord injury and its management  6135
Wagih El Masri(y) and Michael Barnes
24.14	 Diseases of the autonomic nervous system  6150
Christopher J. Mathias and David A. Low
24.15	 The motor neuron diseases  6166
Tom Jenkins, Alice Brockington, and Pamela J. Shaw
24.16	 Diseases of the peripheral nerves  6176
Robert D.M. Hadden
24.17	 Inherited neurodegenerative diseases  6197
Swati Sathe
24.18	 Disorders of the neuromuscular junction  6295
David Hilton-​Jones and Jacqueline Palace
24.19	 Disorders of muscle  6304
	
24.19.1	 Structure and function of muscle  6304
Michael G. Hanna and Enrico Bugiardini
	
24.19.2	 Muscular dystrophy  6310
Kate Bushby and Chiara Marini-​Bettolo
	
24.19.3	 Myotonia  6328
David Hilton-​Jones
	
24.19.4	 Metabolic and endocrine disorders  6334
David Hilton-​Jones and Richard Edwards
	
24.19.5	 Mitochondrial disease  6343
Patrick F. Chinnery and D.M. Turnbull
24.20	 Developmental abnormalities of the central 
nervous system  6350
Chris M. Verity, Jane A. Hurst, and Helen V. Firth
24.21	 Acquired metabolic disorders and the nervous 
system  6368
Neil Scolding
24.22	 Neurological complications of systemic 
disease  6376
Neil Scolding


Contents
xxxii
24.23	 Paraneoplastic neurological syndromes  6384
Jeremy Rees
24.24	 Autoimmune encephalitis and Morvan’s 
syndrome  6393
Camilla Buckley and Angela Vincent
SECTION 25
Disorders of the eye	
Section editor: Christopher P. Conlon
25.1	 The eye in general medicine  6399
Tasanee Braithwaite, Richard W.J. Lee, and Peng T. Khaw
SECTION 26
Psychiatric and drug-​related disorders	
Section editor: Michael Sharpe
26.1	 General introduction  6445
Michael Sharpe
26.2	 The psychiatric assessment of the medical 
patient  6447
Jane Walker, Roger Smyth, and Michael Sharpe
26.3	 Common psychiatric presentations in medical 
patients  6454
	
26.3.1	 Confusion  6454
Bart Sheehan and Thomas Jackson
	
26.3.2	 Self-​harm  6457
Kate E.A. Saunders and Keith Hawton
	
26.3.3	 Medically unexplained symptoms  6460
Michael Sharpe
	
26.3.4	 Low mood  6462
Jane Walker
26.4	 Psychiatric treatments in the medically ill  6465
	
26.4.1	 Psychopharmacology in medical practice  6465
Philip J. Cowen
	
26.4.2	 Psychological treatments  6470
Michael Sharpe and Simon Wessely
26.5	 Specific psychiatric disorders  6475
	
26.5.1	 Delirium  6475
Bart Sheehan
	
26.5.2	 Dementia  6478
Bart Sheehan
	
26.5.3	
Organic psychoses  6482
Curtis McKnight and Jason Caplan
	
26.5.4	
Alcohol misuse  6486
Jonathan Wood
	
26.5.5	
Substance misuse  6490
Stephen Potts
	
26.5.6	
Depressive disorder  6493
Joseph Cerimele and Lydia Chwastiak
	
26.5.7	
Bipolar disorder  6498
Kate E.A. Saunders and John Geddes
	
26.5.8	
Anxiety disorders  6501
Ted Liao and Steve Epstein
	
26.5.9	
Acute stress disorder, adjustment disorders,  
and post-​traumatic stress disorder  6506
Jonathan I. Bisson
	
26.5.10	 Eating disorders  6509
Christopher G. Fairburn
	
26.5.11	 Schizophrenia  6513
Stephen M. Lawrie
	
26.5.12	 Somatic symptom and related  
disorders  6517
Michael Sharpe
	
26.5.13	 Personality disorders  6520
Iain Jordan
26.6	
Changing unhealthy behaviours  6524
	
26.6.1	
Brief interventions for excessive alcohol 
consumption  6524
Amy O’Donnell, Eileen Kaner, and Nick Heather
	
26.6.2	
Obesity and weight management  6529
Susan Jebb and Paul Aveyard
	
26.6.3	
Smoking cessation  6533
Paul Aveyard
26.7	
Psychiatry, liaison psychiatry, and  
psychological medicine  6536
Michael Sharpe
SECTION 27
Forensic medicine	
Section editor: John D. Firth
27.1	 Forensic and legal medicine  6541
Jason Payne-​James, Paul Marks, Ralph Bouhaidar, and  
Steven B. Karch


Contents
xxxiii
SECTION 28
Sport and exercise medicine	
Section editor: John D. Firth
28.1	 Sport and exercise medicine  6565
Cathy Speed
SECTION 29
Biochemistry in medicine	
Section editor: Christopher P. Conlon
29.1	 The use of biochemical analysis for diagnosis  
and management  6577
Brian Shine and Nishan Guha
SECTION 30
Acute medicine	
Section editor: John D. Firth
30.1	 Acute medical presentations  6591
Sian Coggle, Elaine Jolly, and John D. Firth
30.2	 Practical procedures  6644
Elaine Jolly, Sian Coggle, and John D. Firth
Index